Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of…
This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.